Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Hough et al set out to determine incidence and outcomes of early neuromyopathy in patients with persistent acute respiratory distress syndrome (ARDS), and to evaluate the association of neuromyopathy with the use of methylprednisolone in this population.

Neuromuscular Weakness After ARDS